TraceLink is a track and trace network for connecting the life sciences supply chain, providing real-time information sharing for better patient outcomes.
TraceLink's new mobile and web-based application enables any pharmacy in the EU to easily comply with verification and decommissioning requirements under the Falsified Medicines Directive (FMD), while simultaneously delivering a real-time dashboard for business insights on medicine scans, expiry dates, dispensation trends, product inventory and more.
The new Pharmacy Compliance and Digital Information Platform will enable pharmacies to meet EU FMD requirements, which take effect in February 2019.
Pharmacists who use the application will also benefit from user-friendly dashboard analytics providing valuable insights from all transaction information captured within the application.
Pharmacists can opt in to a service within the app linking them to participating pharmaceutical manufacturers, paving the way for a new digital communication channel designed to enhance the information-sharing between pharmaceutical companies and the healthcare providers who dispense the medications.
Once opted in, pharmacists will be able to receive specific and contextual pharmaceutical product information directly from the manufacturer — including details about indications, usage, best practices for product administration, and potential warnings and precautions — empowering them to deliver a more engaging and informative consultation as they dispense medicines to patients.
Shabbir Dahod, President and CEO at TraceLink, said: “TraceLink has broken new ground with this application, addressing a critical information gap that has existed for decades between pharmaceutical companies, pharmacists and patients. Our unique approach of connecting the entire pharmaceutical supply chain on an interoperable network makes TraceLink the only company capable of offering this type of solution and facilitating a new era of real-time information sharing that will transform how the industry provides care to patients.
“This is the first in a series of steps we are taking to augment our effort of eliminating counterfeit drugs from the global marketplace with applications that deliver tangible and meaningful value to an industry that serves hundreds of millions of people who depend on prescription medications to improve their health.”
TraceLink’s new Pharmacy Compliance and Digital Information Platform merges EU FMD compliance capabilities with real-time insights into pharmaceutical products, offering EU pharmacists the ability to:
- Easily submit EU FMD compliance data to their National System — using the integrated camera on their mobile device, pharmacists can scan the 2D data matrix code on the medicine at point of dispense.
- Allow TraceLink to manage all verification and message exchanges with their National System — a module on the application will display the scan status of all pharmaceutical products, allowing pharmacists to view all confirmed verifications, failed verifications, dispensed medicines and decommissioned serial numbers.
- Gain real-time insights into their dispensing operation — ability to track ongoing trends, including information on pharmaceutical products that are dispensed most frequently versus those dispensed infrequently within their pharmacy.
All services within the Pharmacy Compliance and Digital Information Platform will be provided by TraceLink via its secure Life Sciences Cloud where pharmacists can be assured of the confidentiality and anonymous nature of dispensing information.
